NONALCOHOLIC FATTY LIVER DISEASE AND STEATOHEPATITIS

被引：0

作者：

Colak, Yasar ^{[1
]}

Tuncer, Ilyas ^{[1
]}

机构：

[1] Istanbul Goztepe Egitim & Arastirma Hastanesi, Gastroenterol Bilim Dali, Istanbul, Turkey

来源：

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI | 2010年 / 73卷 / 03期

关键词：

Nonalcoholic fatty liver disease (NAFLD); nonalcoholic steatohepatitis (NASH); insulin resistance; inflammation;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Nonalcoholic fatty liver disease (NAFLD) is now recognized as one of the most common liver diseases in the world. It has been used as a general name for conditions ranging from simple steatosis through steatohepatitis to end-stage liver disease ( cirrhosis), and hepatocellular carcinoma. It is associated with insulin resistance and frequently occurs with features of the metabolic syndrome. Disease presentation ranges from asymptomatic elevated liver enzyme levels to cirrhosis with complications of liver failure. In this article we discuss the etiology, pathogenesis and diagnosis of nonalcoholic fatty liver disease as well as approaches to its management.

引用

页码：85 / 91

页数：7

共 50 条

[31] Clinics in Liver Disease: Update on Nonalcoholic Steatohepatitis Sarcopenia and Nonalcoholic Fatty Liver Disease
Kawaguchi, Takumi
Takahashi, Hirokazu
Gerber, Lynn H.
[J]. CLINICS IN LIVER DISEASE, 2023, 27 (02) : 275 - 286
[32] GALLSTONE DISEASE IS NOT ASSOCIATED WITH LIVER FIBROSIS AND NONALCOHOLIC STEATOHEPATITIS IN NONALCOHOLIC FATTY LIVER DISEASE
Yilmaz, Y.
Ayyildiz, T.
Akin, H.
Colak, Y.
Ozturk, O.
Senates, E.
Tuncer, I.
Dolar, E.
[J]. JOURNAL OF HEPATOLOGY, 2013, 58 : S553 - S554
[33] Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation
Younossi, Zobair M.
Marchesini, Giulio
Pinto-Cortez, Helena
Petta, Salvatore
[J]. TRANSPLANTATION, 2019, 103 (01) : 22 - 27
[34] Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: The Disease Burden Grows Foreword
Buchman, Alan L.
[J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2020, 49 (01) : XI - XII
[35] Nonalcoholic fatty liver disease: scintigraphy in the diagnosis of steatohepatitis
da Silva, Alessandro D'Avila
de Mattos, Angelo Zambam
Tovo, Cristiane Valle
Daros, Larissa Faraco
Anselmi, Osvaldo Estrela
Coral, Gabriela Perdomo
de Mattos, Angelo Alves
[J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2021, 67 (11): : 1665 - 1669
[36] Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Beaton, Melanie D.
[J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 26 (06) : 353 - 357
[37] The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Cha J.-Y.
Kim D.-H.
Chun K.-H.
[J]. Laboratory Animal Research, 2018, 34 (4) : 133 - 139
[38] Immunological and molecular basis of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
Radwan, Mohamed M.
Radwan, Basil M.
Nandipati, Kalyana C.
Hunter, William J., III
Agrawal, Devendra K.
[J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (08) : 727 - 738
[39] Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Yoshihisa Takahashi
Keiichiro Sugimoto
Hiroshi Inui
Toshio Fukusato
[J]. World Journal of Gastroenterology, 2015, 21 (13) : 3777 - 3785
[40] The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Shouhed, Daniel
Steggerda, Justin
Burch, Miguel
Noureddin, Mazen
[J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (09) : 797 - 811

← 1 2 3 4 5 →